Overall, our analysis showed that IFN-λ cancer-specific expression may be caused by copy number amplification of IFNL2 and IFNL3 in tumor patients, and most IFN-λ related genes also had copy number amplification and expression upregulation in BSE group. The gene discussed is IFNL3; the disease is cancer.